Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and potassium chloride

acetylleucyl-leucyl-norleucinal has been researched along with potassium chloride in 1 studies

Compound Research Comparison

Studies
(acetylleucyl-leucyl-norleucinal)
Trials
(acetylleucyl-leucyl-norleucinal)
Recent Studies (post-2010)
(acetylleucyl-leucyl-norleucinal)
Studies
(potassium chloride)
Trials
(potassium chloride)
Recent Studies (post-2010) (potassium chloride)
32105318,0403951,764

Protein Interaction Comparison

ProteinTaxonomyacetylleucyl-leucyl-norleucinal (IC50)potassium chloride (IC50)
Sodium/potassium/calcium exchanger 4Homo sapiens (human)174000
Sodium/potassium/calcium exchanger 2Homo sapiens (human)280000

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clifton, GL; Dixon, CE; Hayes, RL; Kampfl, A; Posmantur, R; Whitson, JS; Yang, K; Zhao, X1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and potassium chloride

ArticleYear
Calpain inhibitors protect against depolarization-induced neurofilament protein loss of septo-hippocampal neurons in culture.
    The European journal of neuroscience, 1996, Volume: 8, Issue:2

    Topics: Animals; Calcium Chloride; Calpain; Cells, Cultured; Cysteine Proteinase Inhibitors; Hippocampus; Leupeptins; Membrane Potentials; Nerve Tissue Proteins; Neurofilament Proteins; Neurons; Potassium Chloride; Rats; Septum Pellucidum; Spectrin

1996